TrialInternational journal of clinical practice2009

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

A R Chacra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.